Webinar | RWD’s Value in Autoimmune Disease
RWD’s value in accelerating autoimmune disease diagnosis
Delayed diagnosis of autoimmune diseases is common due to subjective symptoms, lack of definitive testing, and gender bias. This delay can cause worsening symptoms and disease progression in individuals while simultaneously leading to missed research opportunities and reduced revenue for pharma.
Longitudinal real-world data (RWD) collected directly from individuals can help by giving you a comprehensive and objective picture of patients’ day-to-day experiences and quality of life. Watch our on-demand webinar to hear experts discuss how advancements in RWD can:
- Identify new markers for earlier detection, capturing individuals’ unique experiences
- Power AI tools for faster analysis, reducing delays and improving healthcare equity
- Collect data needed to inform health care provider discussions to support diagnosis
Related work
- Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research (January 8, 2026)
- Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals (December 16, 2025)
- Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer (December 2, 2025)
Have questions?
Evidation and the Duke Big Ideas Lab have announced a partnership that aims to find ways to both increase representation of underserved populations and improve adherence among all participants in digital health studies.
The organizations are working together to build an analytic structure that will be available to other digital health researchers, helping to better predict study participation, adherence, and retention. Click below to read more about the project, led by Iredia M. Olaye, PhD, MSc, MHA, of Covered By Group and Evidation, in HealthLeaders.
Good reads
- Digital Divide Goes Beyond Broadband, Rests with Digital Health Literacy
- Paying Research Participants — A Lot — May Be a Key to Increasing Diversity in Studies
- Bioethics International Reveals Index to Score Pharma on Trial Diversity
- $35 Cap on Insulin Could Boost Medication Adherence, Satisfaction
- How Technology Will Shape Healthcare in 2023
What we’ve been up to
- Using Real RWD to Better Understand and Engage Neuro Patients
- Predictors of Seeking Care for Influenza-Like Illness in a Novel Digital Study
- Evidation is a 2023 Best Place to Work!
Upcoming events
Thanks to everyone who took the time to meet with us in San Francisco at this year’s J.P. Morgan Annual Conference and its surrounding events. Our team looks forward to staying in touch and helping you produce better health outcomes in 2023!
Get to know your Evidation team
Bertina Yen, Evidation's Senior Vice President of People & Community
Bertina Yen is Evidation's Senior Vice President of People & Community, where she is responsible for the end-to-end employee experience and building a community that supports everyone's ability to show up as their authentic selves and perform their best work. Prior to joining Evidation, Bertina served as EVP overseeing clinical teams, product management, marketing, and product development at Zynx Health, driving development of evidence-based clinical decision support solutions that improve health and financial outcomes.
Bertina received her BAS from Stanford, then completed her MD and residency in internal medicine at UC San Diego. She also holds an MPH in health services administration from UCLA.
Bertina is the resident DJ at Evidation and sources the music that is played during the All-Employee Meetings. Outside of work, she enjoys hiking, traveling, and watching anything with a live audience (sporting events, plays, movies). She also starts every morning by completing at least one crossword puzzle!
Connect with Bertina here